JUNS
Jupiter Neurosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.28
+0.61%Next report
Analyst consensus
- Next report date
- Dec 2, 2026
- EPS estimate
- -$3.75
- Revenue estimate
- $602.0K
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$5.06
- EPS estimate
- -$3.75
- Revenue actual
- $24.2K
- Revenue estimate
- $400.0K
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 1
- EPS misses (12Q)
- 4
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- -10.6%
- Revenue beats (12Q)
- 0
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Dec 2, 2026